Humane CDKN2A Recombinant

[CDKN2A]

1029

The lyophilized protein is stable for at least 2 years from date of receipt at-20 °C. Upon reconstitution, this cytokine can be stored in working aliquots at 2 degree -8 °C for one month, or at-20 °C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.

[CDKN2A; CDKN2A; ARF; MLM; P14; P16; P19; CMM2; INK4; MTS1; TP16; CDK4I; CDKN2; INK4A; MTS-1; P14ARF; P19ARF; P16INK4; P16INK4A; P16-INK4A; CDKN2; MTS1; CDK4I; MTS-1; p16-INK4; p16INK4A]

[CDKN2A]

[cyclin-dependent kinase inhibitor 2A isoform p16INK4a; Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3; cyclin-dependent kinase inhibitor 2A; CDK4 inhibitor p16-INK4; multiple tumor suppressor 1; cell cycle negative regulator beta; cyclin-dependent kinase 4 inhibitor A; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); cyclin-dependent kinase inhibitor 2A; Cyclin-dependent kinase 4 inhibitor A; CDK4I; Multiple tumor suppressor 1; MTS-1; p16-INK4a]

4502749

NP_000068.1

NM_000077.4

P42771